Form 8-K - Current report:
SEC Accession No. 0001668397-25-000012
Filing Date
2025-02-10
Accepted
2025-02-10 16:15:30
Documents
15
Period of Report
2025-02-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K medp-20250206.htm   iXBRL 8-K 27865
2 EX-99.1 medp-20250210exx991.htm EX-99.1 180305
6 medpace-logoxonxwhitea.jpg GRAPHIC 10438
  Complete submission text file 0001668397-25-000012.txt   363741

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT medp-20250206.xsd EX-101.SCH 1770
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT medp-20250206_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT medp-20250206_pre.xml EX-101.PRE 12500
17 EXTRACTED XBRL INSTANCE DOCUMENT medp-20250206_htm.xml XML 2702
Mailing Address 5375 MEDPACE WAY CINCINNATI OH 45227
Business Address 5375 MEDPACE WAY CINCINNATI OH 45227 (513) 579-9911
Medpace Holdings, Inc. (Filer) CIK: 0001668397 (see all company filings)

EIN.: 320434904 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37856 | Film No.: 25605926
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)